269 related articles for article (PubMed ID: 19450703)
1. 5-Oxo-ETE and the OXE receptor.
Grant GE; Rokach J; Powell WS
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):98-104. PubMed ID: 19450703
[TBL] [Abstract][Full Text] [Related]
2. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
Powell WS; Rokach J
Prog Lipid Res; 2013 Oct; 52(4):651-65. PubMed ID: 24056189
[TBL] [Abstract][Full Text] [Related]
3. Targeting the OXE receptor as a potential novel therapy for asthma.
Powell WS; Rokach J
Biochem Pharmacol; 2020 Sep; 179():113930. PubMed ID: 32240653
[TBL] [Abstract][Full Text] [Related]
4. Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024.
Lin L; Dai F; Wei J; Chen Z
Int Arch Allergy Immunol; 2024; 185(4):301-310. PubMed ID: 38176394
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.
Powell WS; Rokach J
Prog Lipid Res; 2005; 44(2-3):154-83. PubMed ID: 15893379
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.
Powell WS; Rokach J
Biochim Biophys Acta; 2015 Apr; 1851(4):340-55. PubMed ID: 25449650
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes.
Cossette C; Gravel S; Reddy CN; Gore V; Chourey S; Ye Q; Snyder NW; Mesaros CA; Blair IA; Lavoie JP; Reinero CR; Rokach J; Powell WS
Biochem Pharmacol; 2015 Aug; 96(3):247-55. PubMed ID: 26032638
[TBL] [Abstract][Full Text] [Related]
9. Enhanced formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by cancer cells in response to oxidative stress, docosahexaenoic acid and neutrophil-derived 5-hydroxy-6,8,11,14-eicosatetraenoic acid.
Grant GE; Rubino S; Gravel S; Wang X; Patel P; Rokach J; Powell WS
Carcinogenesis; 2011 Jun; 32(6):822-8. PubMed ID: 21393477
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of affinity chromatography ligands for the purification of 5-hydroxyeicosanoid dehydrogenase.
Nagendra Reddy C; Ye Q; Patel P; Sivendran S; Chourey S; Wang R; Anumolu JR; Grant GE; Powell WS; Rokach J
Bioorg Med Chem; 2017 Jan; 25(1):116-125. PubMed ID: 28340986
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells.
Erlemann KR; Rokach J; Powell WS
J Biol Chem; 2004 Sep; 279(39):40376-84. PubMed ID: 15234979
[TBL] [Abstract][Full Text] [Related]
12. Airway epithelial cells synthesize the lipid mediator 5-oxo-ETE in response to oxidative stress.
Erlemann KR; Cossette C; Gravel S; Lesimple A; Lee GJ; Saha G; Rokach J; Powell WS
Free Radic Biol Med; 2007 Mar; 42(5):654-64. PubMed ID: 17291989
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non-human primates.
Miller LA; Cossette C; Chourey S; Ye Q; Reddy CN; Rokach J; Powell WS
Br J Pharmacol; 2020 Jan; 177(2):360-371. PubMed ID: 31655023
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 5-hydroxyeicosanoid dehydrogenase activity in monocytic cells.
Erlemann KR; Cossette C; Grant GE; Lee GJ; Patel P; Rokach J; Powell WS
Biochem J; 2007 Apr; 403(1):157-65. PubMed ID: 17166093
[TBL] [Abstract][Full Text] [Related]
15. TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis.
Hosoi T; Sugikawa E; Chikada A; Koguchi Y; Ohnuki T
Biochem Biophys Res Commun; 2005 Sep; 334(4):987-95. PubMed ID: 16039985
[TBL] [Abstract][Full Text] [Related]
16. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophils.
Sturm GJ; Schuligoi R; Sturm EM; Royer JF; Lang-Loidolt D; Stammberger H; Amann R; Peskar BA; Heinemann A
J Allergy Clin Immunol; 2005 Nov; 116(5):1014-9. PubMed ID: 16275369
[TBL] [Abstract][Full Text] [Related]
17. In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys.
Chourey S; Ye Q; Reddy CN; Cossette C; Gravel S; Zeller M; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
Biochem Pharmacol; 2017 Aug; 138():107-118. PubMed ID: 28476332
[TBL] [Abstract][Full Text] [Related]
18. A biased non-Gαi OXE-R antagonist demonstrates that Gαi protein subunit is not directly involved in neutrophil, eosinophil, and monocyte activation by 5-oxo-ETE.
Konya V; Blättermann S; Jandl K; Platzer W; Ottersbach PA; Marsche G; Gütschow M; Kostenis E; Heinemann A
J Immunol; 2014 May; 192(10):4774-82. PubMed ID: 24733850
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of β-oxidation resistant indole-based 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) receptor antagonists.
Ye Q; Chourey S; Wang R; Chintam NR; Gravel S; Powell WS; Rokach J
Bioorg Med Chem Lett; 2017 Oct; 27(20):4770-4776. PubMed ID: 28943042
[TBL] [Abstract][Full Text] [Related]
20. Substrate selectivity of 5-hydroxyeicosanoid dehydrogenase and its inhibition by 5-hydroxy-Delta6-long-chain fatty acids.
Patel P; Cossette C; Anumolu JR; Erlemann KR; Grant GE; Rokach J; Powell WS
J Pharmacol Exp Ther; 2009 Apr; 329(1):335-41. PubMed ID: 19164464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]